Impact of the COVID-19 pandemic on multidrug-resistant hospital-acquired bacterial infections.

Bongiovanni, M; Barilaro, G; Zanini, U; Giuliani, G

Bongiovanni, M; Barilaro, G; Zanini, U; Giuliani, G.

Bongiovanni M; Department of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland. Electronic address: Marco.Bongiovanni@eoc.ch.
Barilaro G; Department of Autoimmune Diseases, Hospital Clinic, Universitat de Barcelona, Catalonia, Spain.
Zanini U; Pneumology Unit, Garbagnate Hospital, ASST Rhodense, Italy.
Giuliani G; Department of Laboratory Medicine, Garbagnate Milanese, ASST Rhodense, Italy.

J Hosp Infect ; 123: 191-192, 2022 05.

Article in English | MEDLINE | ID: covidwho-1712783

Subject(s)

Bacterial Infections; COVID-19; Anti-Bacterial Agents/therapeutic use; Bacterial Infections/microbiology; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Pandemics/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bacterial Infections / COVID-19 Type of study: Experimental Studies Limits: Humans Language: English Journal: J Hosp Infect Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google